Skip to main content

Table 2 Survivors and non-survivors

From: Serum sclerostin is an independent predictor of mortality in hemodialysis patients

 

Survivors (n = 65)

Non-survivors (n = 26)

  

All (CV +other causes)

CV cause (n = 16)

Other causes (n = 10)

Age, years

37.0 ± 13.6

55.4 ± 23.2a

63.0 ± 20.6a

43.3 ± 22.8c

Gender M/F

37/28

18/8

11/5

7/3

Dialysis vintage, mo

132 (48, 180)

84 (63, 105)

96 (48, 126)

72 (60,84)

Diabetes, n

5

9a

7a

2

Hemoglobin, g/dl

11.7 ± 1.5

11.0 ± 1.7

11.4 ± 1.7

10.6 ± 1.6a

Creatinine, mg/dl

11.6 ± 3.3

9.5 ± 2.9a

9.8 ± 2.6a

9.0 ± 3.5a

Albumin, g/dl

4.2 ± 0.4

4.1 ± 0.6

4.1 ± 0.7

4.1 ± 0.5

Ferritin, ng/ml

519 (175, 691)

570 (278, 902)

598 (270, 862)

570 (276,1106)

Calcium, mg/dl

9.1 ± 1.0

9.4 ± 1.3

9.5 ± 1.6

9.4 ± 0.9

Phosphate, mg/dl

5.4 ± 1.9

4.8 ± 1.8

5.3 ± 1.9

3.9 ± 1.3a

AP, U/l

82 (65, 122)

81 (68, 127)

77 (63, 107)

96 (68,158)

PTH, pg/ml

200 (97, 401)

133 (77, 229)

145 (91, 454)

132 (39,180)

Calcitonin, pg/ml

2.8 (2.0,4.9)

3.2 (2.0, 5.7)

2.0 (2.0, 4.82)

4.6 (2.0, 7.6)

β2micro, μg/ml

28 (22, 34)

25 (16, 30)

24 (19, 30)

30 (12, 45)

IL-6, pg/ml

2.8 (1.4, 4.2)

3.3 (2.3, 12.7)

3.0 (2.3, 6.9)

12.7 (2.0, 27.9)a

Klotho, pg/ml

46.8 (7.6, 82.8)

15.7 (0.1, 103.0)

8.7 (0.1, 45.1)b

114.3 (3.7, 167.7)

FGF 23, RU/ml

134 (122, 159)

147 (129, 197)a

150 (129,311)a

143 (133, 152)

Scl, ng/ml

0.76 (0.50, 1.34)

1.45 (0.83, 1.79)a

1.63 (1.20, 1.87)a

0.84 (0.45, 1.73)

  1. M: male; F: female; AP: Alkaline Phosphatase; PTH: parathormone; β2micro: β2microglobulin; IL-6: interleucin; FGF 23: fibroblast growth factor; Scl: sclerostin; ap < 0.05 vs. survivors; bp = 0.052 vs. survivors; cp < 0.05 vs. CV cause.